Washington, November 14: A sophisticated microscope that offers a “real-time” 3-D analysis of tissue samples has shown promise to reduce the number of needle biopsies, which are needed from women suspected of having breast cancer, in future.
Such instant tests would enable doctors to immediately tell whether they have collected adequate samples of breast tissue, thereby limiting the number of repeat biopsies, say researchers at Georgetown University Medical Center’s Lombardi Comprehensive Cancer Center.